Evercore ISI says three years of biotech underperformance may be ending. Gives its 5 favorite stocks

  • 📰 CNBC
  • ⏱ Reading Time:
  • 26 sec. here
  • 14 min. at publisher
  • 📊 Quality Score:
  • News: 56%
  • Publisher: 72%

Breaking News: Investing Nachrichten

Wall Street,Business,Markets

Evercore initiated coverage on the biotech sector and named its seven favorite stocks it calls 'The Magnificent Seven.'

The outlook on biotechnology is finally turning positive, according to Evercore ISI, which launched coverage of the sector with "an increasingly constructive view" as it expects more room for upside ahead. "After 3 years of painful underperformance, winter is finally thawing and spring just might be in the air," analyst Cory Kasimov wrote in a Monday note. Biotech stocks broadly peaked in early 2021 when interest rates were at a trough, Kasimov noted.

" "We favor names and are initially launching on cos with clear clinical narratives and/or commercial upside. We've got our hands in all the hot areas … oncology, neuro, rare, cardiometabolic, etc.," Kasimov said. The analyst is overweight on five companies: Regeneron , BioMarin , Neurocrine , BridgeBio and Arcellx . He forecasts strong earnings and cash flows for Regernon and highlighted its broad pipeline. That stock has climbed nearly 11% from the start of the year.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 12. in DE
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

iPhone sales will continue to grow despite market pessimism says Evercore ISIiPhone sales will continue to grow despite market pessimism says Evercore ISI
Herkunft: Investingcom - 🏆 450. / 53 Weiterlesen »